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Background: The selection of relevant genes for sample classification is a common task in many gene expression
studies. Although a number of tools have been developed to identify optimal gene expression signatures, they
often generate gene lists that are too long to be exploited clinically. Consequently, researchers in the field try to
identify the smallest set of genes that provide good sample classification. We investigated the genome-wide
expression of the inflammatory phenotype in dendritic cells. Dendritic cells are a complex group of cells that play a
critical role in vertebrate immunity. Therefore, the prediction of the inflammatory phenotype in these cells may
help with the selection of immune-modulating compounds.
Results: A data mining protocol was applied to microarray data for murine cell lines treated with various
inflammatory stimuli. The learning and validation data sets consisted of 155 and 49 samples, respectively. The data
mining protocol reduced the number of probe sets from 5,802 to 10, then from 10 to 6 and finally from 6 to 3.
The performances of a set of supervised classification models were compared. The best accuracy, when using the
six following genes –Il12b, Cd40, Socs3, Irgm1, Plin2 and Lgals3bp– was obtained by Tree Augmented Naïve Bayes
and Nearest Neighbour (91.8%). Using the smallest set of three genes –Il12b, Cd40 and Socs3– the performance
remained satisfactory and the best accuracy was with Support Vector Machine (95.9%). These data mining models,
using data for the genes Il12b, Cd40 and Socs3, were validated with a human data set consisting of 27 samples.
Support Vector Machines (71.4%) and Nearest Neighbour (92.6%) gave the worst performances, but the remaining
models correctly classified all the 27 samples.
Conclusions: The genes selected by the data mining protocol proposed were shown to be informative for
discriminating between inflammatory and steady-state phenotypes in dendritic cells. The robustness of the data
mining protocol was confirmed by the accuracy for a human data set, when using only the following three genes:
Il12b, Cd40 and Socs3. In summary, we analysed the longitudinal pattern of expression in dendritic cells stimulated
with activating agents with the aim of identifying signatures that would predict or explain the dentritic cell
response to an inflammatory agent.
Background
Genome-wide screening of expression profiles has pro-
vided a broad perspective on gene regulation in health and
disease. Gene expression is controlled over a wide range
through complex interplay between DNA regulatory pro-
teins, microRNA molecules and epigenetic modifications
determining transcript production [1-3]. For example,
gene expression profiles in mouse dendritic cells (DCs) in
response to microbial organisms and their components
have been studied using a functional genomics approach
and the molecular patterns involved in DCs activation
have been determined [4-7]. However, the high-dimen-
sionality inherent in genome-wide analyses makes it diffi-
cult to extract biologically useful information from gene
expression data. Early attempts at genome-wide expression
analysis used unsupervised methods to identify groups of
genes or conditions with similar expression profiles [8-10];
the observation that functionally related or co-regulated
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any medium, provided the original work is properly cited.genes often cluster together was used to provide biological
insight. Classification studies in the field of microarray
analysis have become important for the development of
diagnostic tests. One of the most common approaches for
supervised classification is binary classification, which
distinguishes between two types of phenotype: positive, for
example compound A-treated samples, and negative, often
control or compound B-treated samples. A collection of
samples with known type labels is used to train a classifier
that is then used to classify new samples. For example, the
supervised classification models Support Vector Machines
[11], Classification Trees [12] and Artificial Neural
Networks [13] have led to the generation of functional
gene signatures for haematological malignancies [8,14-16],
and for the identification of molecular markers that
provide accurate diagnosis, prognosis and selection of
treatment regimens for human diseases [17-20]. These
methods are able to identify genes and, consequently gene
networks, associated with particular phenotypes. More
recently, supervised classification models combining cross
validation and heuristic search strategies have been used
to discover optimal expression signatures in cancer
[21-23]. However, despite the number of classification
methods that have been developed for this kind of knowl-
edge extraction, such knowledge has not yet been widely
used in diagnostic or prognostic decision-support systems
[13]. This is partly due to the variability of the results
obtained [24] and also to the different data sets used
[25,26].
Few methods have been used to identify specific expres-
sion signatures that could contribute to the molecular
diagnosis of inflammatory-based diseases. The Random
Forests method has been used to generate a 44-gene signa-
ture in DCs to distinguish between inflammatory and non-
inflammatory stimuli, but this gene signature is too large
for clinical exploitation [5]. Here, we report a data mining
protocol developed through the analysis of a database gen-
erated from microarray experiments with DCs exposed to
various stimuli able to induce cell activation. This protocol
allowed the selection of a small set of genes which were
subsequently used by supervised classification models to
make inferences concerning the inflammatory state of the
samples.
Results
The Knowledge Extraction Protocol (KEP), depicted in
Figure 1, was used to select relevant probe sets (genes)
and to train supervised classification models to discrimi-
nate between “inflammatory” and “not inflammatory”
phenotypes of DCs.
Data Selection
Mouse data: two microarray data sets, namely the
Learning Data Set and the Validation Data Set,w e r e
defined. The Learning Data Set included the results
obtained from microarray experiments performed with:
Affymetrix MGU74Av2 arrays (89 samples - 9 different
stimuli) [5], Affymetrix MOE430A arrays (44 samples -
4 different stimuli) and MOE430A 2.0 arrays (22 sam-
ples - 2 different stimuli). The Validation Data Set the
results of microarray experiments performed with: Affy-
metrix MGU74Av2 arrays (43 samples - 6 different sti-
muli) [5] and MOE430A 2.0 arrays (6 samples - 1
stimulus; this stimulus is the only one that was not with
the DC cell line D1 [27], but used bone marrow-derived
DCs (BMDC) [28]).
Pre-processing
The differences in array formats required the data to be
standardised. GeneChip Mouse Expression 430
(MOE430A 2.0) is the latest version of Affymetrix
mouse arrays and contains 22,600 probe sets. All the
probe sets of the MOE430A array are included in the
MOE430A 2.0 array. The older mouse array,
MGU74Av2, contains 12,488 probe sets that only par-
tially match the probe sets of its more recent releases.
Affymetrix provides “best match” probe set tables which
allow the mapping of equivalent probe sets between dif-
ferent array releases.
The following pre-processing steps were performed: a)
Probe set best matching between MOE430A and
MGU74Av2. This resulted in 8,904 probe sets, also
included in the MOE430A 2.0 array; b) Probe set filter-
ing based on Affymetrix grading A annotation. This step
retained 8,349 probe sets out of the 8,904 available; c)
Probe set filtering based on expression signals. Every
probe set whose expression signal was below 100 was
discarded, such that 5,802 probe sets of the 8,349 avail-
able were retained; d) per sample Z-score computation.
The pre-processing procedure generated the Pre-pro-
cessed Learning Data Set, which consisted of 155 sam-
ples (15 different stimuli), and the Pre-processed
Validation Data Set, which consisted of 49 samples (7
different stimuli). Both data sets contained the same
5,802 probe sets. The class counts for the two data sets
are summarised in Table 1 and the detailed list of the
experiments and array types is reported in Additional
file 1.
Feature Selection
Feature selection involves the identification and removal
of non significant features. The probe sets which provide
no information helping to discriminate between “inflam-
matory” and “not inflammatory” states of the samples
are thereby removed from the analysis.
The Weka software environment was used for feature
selection [29]. The feature selection task was performed
through an ADTree-based wrapper schema (default
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Page 2 of 13Figure 1 Knowledge Extraction Protocol. Data are selected (Data Selection) from the Microarray Database to obtain the Learning Data Set
which pre-identifies the relevant genes (Selected Features Learning Data Set). Selected genes are used to train several DM models whose
performance (Model Learning and Performance Estimation) is summarised (Learning Performance Report). DM models are validated (Validation)
to obtain the Validation Performance Report, and the selected genes are used to query the Ingenuity Pathway Analysis software (IPA software).
Functional Gene Selection exploits the Ingenuity Graph to obtain the Reduced set of Genes that is used for Model Learning. The Validation task
generates the Post-processing Performance Report.
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Data Set. This step selected an expression signature of
ten probe sets (Table 2) from among the initial 5,802,
which generated the Selected Features Learning Data
Set.
Model Training and Performance Estimation
This task, implemented through the Weka software envir-
onment, used the Selected Features Learning Data Set to
train, evaluate and compare the performance of the fol-
lowing supervised classification models: ZeroR, IB-3, C4.5,
Logistic, Multi Layer Perceptron (MLP), Naïve Bayes (NB),
Random Forest (RF), Support Vector Machines (SMO-puk)
and Tree Augmented Naïve bayes (TAN).
These models were chosen because they are state-of-
the-art for solving supervised classification problems.
ZeroR uses the majority criteria to classify a sample, i.e. it
classifies each sample according to the majority of the
class distribution. The weighted averages, estimated
through ten repeated 10-fold cross validations, of the fol-
lowing performance measures are reported in Table 3:
Precision, Recall, F-measure, ROC and Accuracy. ZeroR
was used as the baseline measure of performance, and the
performance of the other models was assessed from ROC
values: the ROC values were 97.5% for each C4.5, 100%
for MLP99.9% for IB-3 99.8% for RF, 99.0% for SMO-puk,
and 99.2% for TAN,a n d9 8 . 6 %f o rb o t hLogistic and NB.
However, using accuracy to compare the supervised classi-
fication models, a different picture is obtained. The model
with the highest accuracy value was RF (99.1%). The other
accuracy values were 98.6% for both SMO-puk and MLP,
98.1% for IB-3, 96.3% for both TAN and C4.5, 95.5% for
Logistic and 94.2%, the lowest value, for NB.
Validation
Supervised classification models, which generate the
selected gene expression signature, need to be able to
classify data sets other than the one they were trained on
if they are to be useful. Therefore, the performance of the
supervised classification models was evaluated by exploit-
ing the Selected Features Validation Data Set (Table 4).
The Bayesian models, NB (93.0%) and TAN (92.8%),
attained the highest ROC values and both IB-3 (92.6%)
and C4.5 (91.2%) gave good ROC values. However, the
ROC values were substantially lower for RF (89.6%), MLP
(88.1%), SMO-puk (86.7%) and Logistic (86.6%). The
ZeroR model gave an ROC value of 50% confirming, as
was expected, that it behaves like a random guessing
model. A different picture emerged when the accuracy
performance measure was used. Indeed, the best accuracy
value (93.9%) was for C4.5 and RF. The accuracy value
for the TAN model was 91.8% and that for SMO-puk was
89.8%. The accuracy values were lower for NB (87.8%),
IB-3 (85.7%) and Logistic (81.6%). The model with the
worst accuracy value was MLP (77.6%).
Functional Gene Selection
The annotations of the ten selected genes (Table 2)
indicate that four, namely Socs3, Irgm1, Il12b and Cd40,
are associated with known immune-related functions.
Expression of six of the ten selected genes differs
between the “non inflammatory” and “inflammatory”
classes with an absolute Log2 FoldChange (LogFC)
greater than 1. A heatmap (Figure 2) was established for
Table 2 Selected Genes
Feature Name Chromosome Gene
Symbol
Gene Title Entrez Gene
ID
101481_at1415791_at 5 Rnf34 ring finger protein 34 80751
92232_at-1416576_at 11 Socs3 suppressor of cytokine signaling 3 12702
97409_at-1418825_at 11 Irgm1 immunity-related GTPase family M member 1 15944
100779_at-
1419530_at
11 Il12b interleukin 12b 16160
93347_at-
1421873_s_at
13 Rab24 RAB24, member RAS oncogene family 19336
102062_at-
1423416_at
9 Smarcc1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin,




14 Dock5 dedicator of cytokinesis 5 68813
98589_at-1448318_at 4 Plin2 perilipin 2 11520
97507_at-1448380_at 11 Lgals3bp lectin, galactoside-binding, soluble, 3 binding protein 19039
92962_at-
1449473_s_at
2 Cd40 CD40 antigen 21939
Table 1 Frequency of the class variable for Pre-processed
Data Sets
Pre-processed Data Set Inflammatory Not Inflammatory
Learning 106 49
Validation 32 17
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selected genes for the “non inflammatory” and “inflam-
matory” experiments, calculated on the median expres-
sion value for that gene. Il2b and Socs3 are up-regulated
with LogFC values of 4.1 and 2.7, respectively. Irgm1,
Plin2, Lgals3bp and Smarcc1 are down-regulated with
LogFC values of -1.1, -5.6, -2.7 and -2.9, respectively in
the samples induced with inflammatory stimuli. The
remaining four genes, namely Cd40, Dock5, Rnf34 and
Rab24, show a level of up-regulation or down-regulation
resulting in a value of LogFC which is smaller than 1.
To characterize the selected gene expression signature
further, the ten genes were examined with Ingenuity
®
Pathway Analysis (IPA) software and the Ingenuity
®
Knowledge Base (IKB). The IPA software was queried to
find the biological interactions (direct and indirect)
among the ten genes. The top network retrieved (IPA
score equal to 16), depicted in Figure 3, contains six genes
of the selected gene expression signature (grey nodes in
Figure 3) and 25 further genes (white nodes in Figure 3)
that were added by the IKB to build the network. The bio-
logical functions associated with this network are the fol-
lowing: Cellular Growth and Proliferation, Haematological
System Development and Function, Humoral Immune
Response.
The molecular and cellular functions of the genes
included in the selected gene expression signature were
analysed with IPA (Table 5). This identified the Infection
Mechanism to be the top function related to “Diseases
and Disorders”,t h eCellular Growth and Proliferation to
be the top function related to “Molecular and Cellular
Functions” and the Haematological System Development
and Function to be the top function related to “Physio-
logical System Development and Function”.
A smaller set of genes (Table 6) was obtained by
removing those genes not included in the IPA top net-
work (Figure 3). The performances of the classification
models which exploit this reduced set of genes on the
Selected Features Validation Data Set are reported in
Table 7. The ROC values of RF, MLP, SMO-puk and IB-3
were not significantly affected by the functional gene
selection step. However, the ROC values for NB, TAN
and C4.5 increased whereas that for Logistic decreased.
Table 4 Validation Performance Report
Precision Recall F-measure ROC Accuracy Errors
ZeroR 42.6 65.3 51.6 50.0 65.3 17/49
IB-3 85.6 85.7 85.6 92.6 85.7 07/49
C4.5 94.4 93.9 93.7 91.2 93.9 03/49
Logistic 81.9 81.6 80.7 86.6 81.6 09/49
MLP 77.2 77.6 76.4 88.1 77.6 11/49
NB 87.7 87.8 87.6 93.0 87.8 06/49
RF 93.9 93.9 93.8 89.6 93.9 03/49
SMO-puk 90.1 89.8 89.5 86.7 89.8 05/49
TAN 91.9 91.8 91.7 92.8 91.8 04/49
Table 3 Learning Performance Report
Precision Recall F-measure ROC Accuracy
min mid max min mid max min mid max min mid max min mid max
ZeroR 46.8 46.8 46.8 68.4 68.4 68.4 55.5 55.5 55.5 47.9 47.9 47.9 68.4 68.4 68.4
IB-3 97.4 98.1 98.7 97.4 98.1 98.7 97.4 98.1 98.7 99.9 99.9 100.0 97.4 98.1 98.7
C4.5 94.2 96.3 98.1 94.2 96.3 98.1 94.1 96.3 98.1 92.9 97.5 98.9 94.2 96.3 98.1
Logistic 94.4 95.6 96.9 94.2 95.5 96.8 94.2 95.5 96.8 98.3 98.6 98.9 94.2 95.5 96.8
MLP 98.2 98.7 98.8 98.1 98.6 98.7 98.1 98.6 98.7 99.9 100.0 100.0 98.1 98.6 98.7
NB 93.7 94.4 95.1 93.5 94.2 94.8 93.6 94.2 94.9 98.3 98.6 98.9 93.6 94.2 94.8
RF 96.8 99.1 100.0 96.8 99.1 100.0 96.7 99.1 100.0 98.5 99.8 100.0 96.8 99.1 100.0
SMO-puk 98.2 98.7 98.8 98.1 98.6 98.7 98.1 98.6 98.7 98.6 99.0 99.1 98.1 98.6 98.7
TAN 94.9 96.3 98.1 94.8 96.3 98.1 94.8 96.2 98.1 98.9 99.2 99.4 94.8 96.3 98.1
Figure 2 Heatmap of the 10 selected genes calculated on the
testing set. The heatmap reports the ratio between the log2 mean
expression value for each condition and the median values of each
probe set. The LogFC value is reported next to the Gene Symbol for
each gene. Red indicates up-regulated and blue down-regulated
probe sets. The probe sets (rows) are grouped according to their
similarity by hierarchical clustering using complete linkage
(Euclidean distance).
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affected by the functional gene selection step; they
increased from 85.7% to 91.8% for IB-3, from 77.6% to
81.6% for MLP and from 81.6% to 83.7% for Logistic,b u t
decreased from 93.9% to 85.7% for both C4.5 and RF.
The heatmap in Figure 4 shows the modulation of the six
genes in the Selected Features Validation Data Set.I l 2 b ,
Socs3 and Cd40 were up-regulated in the Selected Fea-
tures Validation Data Set also; with Cd40 being up-regu-
lated (LogFC = 4.5) in the Selected Features Validation
Data Set in comparison with the Selected Features Learn-
ing Data Set (LogFC = 0.45). Furthermore, Irgm1 was up-
regulated (LogFC = 1.9) in the Selected Features Valida-
tion Data Set but down-regulated in the Selected Features
Learning Data Set (LogFC = -5.6). Plin2, Lgals3bp and
Smarcc1 were not modulated in the Selected Features
Validation Data Set but were down-regulated in the
Selected Features Validation Data Set (Figure 2). The
best classification models, i.e. IB-3 and TAN, misclassified
four of the 49 samples belonging to the Selected Features
Validation Data Set. One sample was genuinely allocated
to the wrong group, whereas two were known to be
labelled with the wrong class and one was known to be
an outlier.
Reducing the number of genes from ten to six on the
basis of the information derived from the top network
generated by IPA gave satisfactory accuracy values.
Therefore, a further Functional Gene Selection step was
Figure 3 Top IPA generated network. The figure illustrates the graphical representation of the Ingenuity Pathway Analysis software. Each node
contains comprehensive information on a gene’s function, how that gene is regulated, its direct neighbours, and synonyms, Genes are
represented as nodes and the biological relationship between two nodes is represented as an edge: dashed lines if relationship is indirect and
continuous lines are for direct relationships. Nodes are displayed using various shapes that represent the functional class of the gene product
(legend in the top left). The output of the IPA query is exploited for Biological Annotation from the IPA Knowledge Database. The top network
found by IPA concerns cellular growth and proliferation and the humoral immune response. Six (grey nodes) among the ten input genes show
more than one interaction (also indirect) in the network built by IPA.
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linked to each other in the IPA top network: Cd40,
Il12b and Socs3 (Figure 5). The results of the Validation
task, when only the above genes were used, are reported
in Table 8. The model that giving the best accuracy
value was SMO-puk (95.9%). The second best accuracy
value (91.8%) was with IB-3 and NB. Logistic and TAN
gave the same, satisfactory, accuracy value (89.8%). That
for MLP was 87.8% and the lowest value (85.7%) was for
C4.5 and RF. The best model, i.e. SMO-puk, misclassi-
fied two of the 49 samples. These samples were those
known to be labelled in the wrong class. These findings
confirm that the three genes are sufficient for correct
classification of all the samples of the Selected Features
Validation Data Set.
A 3-gene signature associated with inflammation in
Human Dendritic Cells
Human Data. To test the general applicability of the
proposed protocol, Affymetrix HGU133A gene
expression microarray data for 27 human samples (cor-
responding to nine time series) was used to validate the
performance of the 3-gene signature classifiers, also in
human dendritic cells. A data set for human monocyte-
derived dendritic cells treated with Mycobacteria tuber-
culosis was derived from a previous study [30] and
tested (Table 9). All the supervised classification models,
with the exception of IB-3 and SMO-puk, achieved an
accuracy of 100% indicating that the 3-gene signature
selected on mouse DCs indeed corresponds to a general
signature of inflammation in dendritic cells in both
human and mouse systems. Therefore, we suggest
CD40, Il12b and Socs3 can be considered to be the mas-
ter genes of inflammation and activation in DCs.
Discussion
In this study, we used advanced supervised analysis to
derive specific transcriptional signatures from differen-
tially activated DCs and assessed whether this molecular
signatures can define DCs phenotypes in vitro. DCs form
Table 5 Biological functions related to the selected genes.
Diseases and Disorders
Name p-value # Molecules
Infection Mechanism 4.32E-07 - 4.79E-02 4
Genetic Disorder 1.30E-06 - 4.33E-02 4
Hematological Disease 1.30E-06 - 1.91E-02 5
Immunological Disease 1.30E-06 - 4.27E-02 5
Gastrointestinal Disease 1.33E-06 - 3.80E-02 4
Molecular and Cellular Functions
Name p-value # Molecules
Cellular Growth and Proliferation 1.23E-07 - 4.72E-02 5
Lipid Metabolism 4.32E-06 - 2.05E-02 4
Small Molecule Biochemistry 4.32E-06 - 4.13E-02 5
Cell Signaling 4.35E-06 - 4.13E-02 4
Cellular Development 6.63E-06 - 4.86E-02 5
Physiological System Development and Function
Name p-value # Molecules
Hematological System Development and Function 1.23E-07 - 4.86E-02 6
Tissue Development 1.23E-07 - 3.93E-02 6
Humoral Immune Response 4.32E-07 - 2.99E-02 2
Organismal Survival 6.36E-06 - 4.67E-04 5
Cell-mediated Immune Response 6.63E-06 - 3.86E-02 5
Table 6 Reduced set of Genes.
Feature Name Chromosome Gene Symbol Gene Title Entrez Gene ID
92232_at-1416576_at 11 Socs3 suppressor of cytokine signaling 3 12702
97409_at-1418825_at 11 Irgm1 immunity-related GTPase family M member 1 15944
100779_at-1419530_at 11 Il12b interleukin 12 b 16160
98589_at-1448318_at 4 Plin2 perilipin 2 11520
97507_at-1448380_at 11 Lgals3bp lectin, galactoside-binding, soluble, 3 binding protein 19039
92962_at-1449473_s_at 2 Cd40 CD40 antigen 21939
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of the immune system. Studies in mice have demon-
strated that cellular vaccination with antigen-bearing
DCs is efficient in stimulating antigen-specific T cell
responses. Because of the immune-regulating functions
of DCs, the therapeutic use of DCs in medicine to control
immune responses is an attractive strategy. DCs are
indeed regarded as a powerful tool for anti-cancer immu-
notherapy [31]. In addition, to treat patients suffering
from autoimmune or inflammatory diseases, it is desir-
able to downregulate immune responses in an antigen-
specific or a tissue-specific manner without causing sys-
temic immunosuppression. Moreover, graft-versus-host
disease (GVHD) and graft rejection are the most serious
problems in transplantation medicine, and control of
alloreactive immune responses is the key to overcoming
these problems. Therefore, antigen-specific negative reg-
ulation by DCs with immunosuppressive function is con-
sidered to be a promising treatment method also in the
field of transplantation medicine [32,33]. In summary, a
number of studies describe the generation of DCs from
sources aiming at cell therapy [34,35]. Nevertheless, no
methods exist today to test quality of the cell type gener-
ated. Therefore, a molecular test that could confirm DCs
quality before their use in clinic will provide valuable
information into the field of DCs therapies.
The problem of sample classification via gene signa-
tures derived from transcriptional profiling has received
increasing attention in the context of DNA microarrays.
We used various aspects of the evaluation of gene selec-
tion approaches by combining the analysis of different
markers of performance. First, we selected a list of
genes, from whole-genome profiling of DCs, able to dis-
criminate DC activation state. Second, to reduce the
bias due to the classification model, we estimated differ-
ent parameters through optimisation on an independent
validation data set.
The Knowledge Extraction Protocol (KEP) (Figure 1)
selected ten genes that, on the Selected Features
Table 7 Post-processing Performance (Functional Gene
Selection I)
Precision Recall F-measure ROC Accuracy Errors
ZeroR 42.6 65.3 51.6 50.0 65.3 17/49
IB-3 91.8 91.8 91.8 90.8 91.8 04/49
C4.5 86.8 85.7 85.9 86.3 85.7 07/49
Logistic 84.3 83.7 83.9 91.5 83.7 08/49
MLP 82.8 81.6 81.9 86.8 81.6 09/49
NB 87.8 87.8 87.8 89.9 87.8 06/49
RF 86.8 85.7 85.9 90.1 85.7 07/49
SMO-puk 89.7 89.8 89.7 88.1 89.8 05/49
TAN 91.9 91.8 91.7 90.1 91.8 04/49
Figure 4 Heatmap of the six selected genes calculated on the
validation data set. The heatmap reports the ratio between the
log2 mean expression value for each condition and the median
values of each probe set. The LogFC values are reported next to the
Gene Symbol for each gene. Red indicates up-regulated and blue
down-regulated probe sets. The probe sets (rows) are grouped
according to their similarity by hierarchical clustering using
complete linkage (Euclidean distance).
Figure 5 IPA functional relationship among the 3 selected
features. Genes are represented as nodes and the biological
relationships between two nodes are represented as edges: dashed
lines indicate that the relationship is indirect. (A) Activation, (E)
Expression (includes metabolism/synthesis for chemicals), (LO)
Localisation, (PD) Protein-DNA binding (PP) Protein-Protein binding,
(TR) Translocation.
Table 8 Post-processing Performance (Functional Gene
Selection II)
Precision Recall F-measure ROC Accuracy Errors
ZeroR 42.6 65.3 51.6 50.0 65.3 17/49
IB-3 91.9 91.8 91.7 93.5 91.8 04/49
C4.5 85.6 85.7 85.6 83.5 85.7 07/49
Logistic 89.7 89.8 89.7 91.5 89.8 05/49
MLP 88.3 87.8 87.9 92.5 87.8 06/49
NB 91.8 91.8 91.8 93.2 91.8 04/49
RF 85.6 85.7 85.6 84.7 85.7 07/49
SMO-puk 96.2 95.9 95.9 94.1 95.9 02/49
TAN 90.0 89.8 89.9 89.3 89.8 05/49
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tory” and “not inflammatory” stimuli with an accuracy
of 93.9% for C4.5 and RF and of 91.8% for TAN.
Six of the ten genes selected were modulated in the
Selected Features Learning Data Set between the “not
inflammatory” and “inflammatory” classes with an abso-
lute Log2FoldChange (LogFC) greater than 1. The heat-
map of the selected genes is shown in Figure 2 and
revealed that two of them were up-regulated and four
were down-regulated. Il2b, Socs3 and Cd40 were up-
regulated (Figure 4) also in the Selected Features Valida-
tion Data Set; notably, Cd40 was up-regulated (4.5
LogFC) in the inflammatory state samples of the Selected
Features Validation Data Set, compared to 0.45 LogFC
in the Selected Features Learning Data Set.P l i n 2 ,
Lgals3bp and Smarc1 were not substantially modulated
in the Selected Features Validation Data Set and were
down-regulated in the Selected Features Learning Data
Set. Modulation of these selected genes should be further
investigated biologically to validate these findings.
KEP misclassified four of the 49 samples of the Selected
Features Validation Data Set;o n es a m p l ew a sd e r i v e d
from D1 cells treated with the Listeria monocytogenes
EGD for 4 h replicate A, and three samples from D1 trea-
ted with the Listeria innocua 0 h replicates A and B and 8
h replicate A. The two time 0 h samples of the Listeria
innocua experiment were known to be mislabelled, and
the sample 8 h was found to be an outlier. Hierarchical
clustering analysis of the samples from this Listeria
monocytogenes EGD experiment did not show any anom-
aly that might provide an explanation for the misclassifi-
cation (data not shown). Remarkably, in the Selected
Features Validation Data Set, samples from experiments
involving cells from different sources (e.g. bone-marrow
derived DCs) were not misclassified. This suggested that
the KEP presented in this work may discriminate inflam-
matory signatures for DCs from diverse sources.
Several methods, including traditional statistical techni-
ques and state of the art computer-intensive methodolo-
gies, have been investigated to predict inflammatory
signatures in DCs. Activation of DCs with LPS and with
IFN-b have been shown to generate cells prone to pro-
duce Th1 attractants that are effective for adoptive
immune cancer therapy [36,37]. It has been also demon-
strated that DCs exposed to supernatants derived from
tumours treated with some cytotoxic drugs are capable
to modulate co-stimulatory markers and to trigger T cell
responses [38]. A 44-gene signature in DCs, able to dis-
criminate between different functional states, is described
in [5]. Here, we report a significant improvement over
the previous work by reducing the number of genes in
the signature and by testing their performance with DCs
derived from different hosts, namely mouse and human.
We selected a signature of inflammation based on the
expression of ten genes and demonstrated that this list
could be further reduced to three genes without signifi-
cantly affecting the classification performance. The three
genes, namely CD40, Il12b and Socs3, can thus be con-
sidered to be the master genes of activation/inflammation
in DCs. CD40 mediates a broad variety of immune and
inflammatory responses, and the ligand-receptor interac-
tion is responsible for immune activation; Il12b is a part
of the IL12 cytokine complex, a cytokine that acts on T
and natural killer cells, and has a broad range of biologi-
cal activities, the most important being the induction of
Th1 cells development; the Socs3 gene encodes a mem-
ber of the STAT-induced STAT inhibitor (SSI) family,
also known as the suppressor of cytokine signalling
(SOCS) family. SSI family members are cytokine-induci-
ble negative regulators of cytokine signalling [39-42].
Therefore, the regulation of these genes in concert in
DCs suggests that they may serve as molecular markers
of inflammation/activation both in human and murine
DCs.
Conclusions
Experimental and bioinformatics strategies of this type
may be used to improve treatment decisions for other
inflammatory contexts, particularly chronic diseases.
T h ew h o l e - g e n o m ea p p r o a c hh o l d st h ep r o m i s et o
define the DCs functional quality that results in a better
prediction of the stimulatory capacity of the cells. This
approach may become a powerful strategy in persona-
lised medicine.
Methods
The Knowledge Extraction Protocol (Figure 1) is based
on Data Mining (DM) [43,44] and consists of the fol-
lowing tasks; Data Selection, Pre-processing, Feature
Selection, Model Training and Performance Estimation,
Validation and Functional Gene Selection.
Data Selection
Mouse data: all time-series experiments of the Learning
Data Set used the murine cell line D1 [27] treated for 0,
Table 9 Performance of 3-genes signature classifiers on
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Page 9 of 132, 4, 8, 12 and 24 hours with “inflammatory” (CpG, Shis-
tosomula eggs, LPS, Leishmania promastigote, Zymosan,
polyIC, Listeria monocytogenes, Listeria innocua, Borde-
tella pertussis, Bordetella parapertussis, Lactobacillus
paracasei, Lactobacillus lactis)a n d“not inflammatory”
stimuli (Shistosomula SLA, Leishmania amastigote, dexa-
methasone) [5]. The Validation Data Set includes
experiments performed with “not inflammatory” (cho-
lera toxin) and “inflammatory” stimuli (Listeria monocy-
togenes EGD-e, EGD-d, EGD-p, Listeria innocua,L P S ) .
Time 0 hours experiments were labelled as “not inflam-
matory”. All the experiments were performed with D1
cells, with the exception of the LPS time series that was
produced with bone marrow-derived murine DCs [27].
Most experiments were done on biological duplicates.
Total RNA was extracted, labelled and hybridized to an
Affymetrix GeneChip
® as described in [5].
Human Data: the human dataset used for the valida-
tion for human DCs was obtained from a previous study
[30]. Briefly, human DCs were differentiated from
human circulating monocytes and treated with M.
tuberculosis H37Rv at multiplicity of infection of 1 for 4,
18 and 48 h. Total RNA was extracted, labelled and
hybridised to a Human U133A Affymetrix GeneChip
®
as described in [30].
For all the arrays, both with human and mouse sets,
signal summarisation was performed using the Affyme-
trix GeneChip Operating Software
® (GCOS) and the
MicroArray Suite version 5 (MAS 5.0) algorithm with
scaling intensity target set to 100.
Pre-processing
Mouse Data: three kinds of arrays (Affymetrix
® MOE430
2.0, MOE430A 2.0 and MGU74Av2) were used. All
probe sets represented on the GeneChip
® MOE430A
(22,690 probe sets) are included on the GeneChip
®
MOE430A 2.0 array; the MG-U74Av2 array contains dif-
ferent probe sets (12,488 probe sets). The probe sets
associated with the MOE430A, MOE430A 2.0 and MG-
U74Av2 arrays mapped with the “mgu74v2_vs_mou-
se430_best_match” annotation table from Affymetrix
http://www.affymetrix.com/support/technical/compari-
son_spreadsheets.affx?pnl = 1_2#1_2. Only the probe sets
associated with the Affymetrix annotation Grade “A”
were retained (8,349 probe sets). The pre-processing task
removes from the Learning Data Set/Validation Data Set
those probe sets associated with high levels of noise, and
labels samples as inflammatory or not inflammatory and
thus generates the Pre-processed Learning Data Set/Pre-
processed Validation Data Set.T h en o i s yp r o b es e t sa r e
removed by using the probe set filter procedure which
s e l e c t sap r o b es e ti nt h ec a s ew h e r ei t ss i g n a le x c e e d s
100 for at least two samples. The pre-processed data sets
consisted of 5,802 features (probe sets). Note that the
pre-processing task transforms the Learning Data Set/
Validation Data Set in such a way that each measure-
ment of a probe set, associated with a given point in
time, becomes an observation in the corresponding Pre-
processed Learning Data Set/Pre-processed Validation
Data Set.T h ePre-processed Learning Data Set consisted
of 155 cases (15 stimuli, 30 time series) and the Pre-
processed Validation Data Set consisted of 49 cases (7
stimuli, 12 time series). The counts of the class variables
are reported in Table 1. Intensity data was used to com-
pute per-sample Z-score.
Human Data: Affymetrix NetAffx tool http://www.affy-
metrix.com/index.affx was used to retrieve all human
corresponding orthologous probe sets for Cd40, Il12b
and Socs3 from the Affymetrix
® GeneChip
® HGU133 A
array. In case of multiple probe sets for the same gene, as
was the case for Cd40, we chose the most similar in gene
sequence mapping between the human and mouse gen-
omes. Intensity data was used to compute per-sample Z-
scores. The human dataset resulted from three probe sets
and 27 samples (1 stimulus, 9 time series) all labeled as
“inflammatory”.
Feature Selection
KEP performs the feature selection task through the
A D T r e ea l g o r i t h m[ 4 5 ]a p p l i e dt ot h ePre-processed
Learning Data Set. The Weka software environment,
Ver. 3.5.6 [29], was used with 10-fold cross validation to
obtain the Selected Features Learning Data Set.
Model Learning and Performance Estimation
Model Learning and Performance Estimation, applied to
the Selected Features Learning Data Set, is concerned
with the training and estimation of the classification per-
formance of the following DM models; ZeroR, Nearest
Neighbour, C4.5, Logistic, Multi Layer Perceptron, Naïve
Bayes, Random Forest, Support Vector Machines and
Tree Augmented Naïve Bayes. ZeroR uses the majority
criteria to classify a sample, i.e. it classifies each sample
according to the majority of the class distribution. It is
useful to provide a baseline measure of performance.
Nearest Neighbour [46] (IB-k with k = 3 and default
learning parameter values) is a k nearest neighbour algo-
rithm. C4.5 [47] (J48 with default learning parameter
values) is a decision tree, Logistic [48] is a multinomial
logistic regression model with a ridge estimator (default
learning parameter values), Multi Layer Perceptron [49]
(MLP with default learning parameter values) is a feed-
forward neural network. Naïve Bayes [49] (NB default
learning parameter values) is a widely used supervised
classifier. Random Forest [50] (RF with default learning
parameter values) is the well-known supervised classifica-
tion model from Leo Breiman. Support Vector Machines
[51] (SOM with the puk kernel and default learning
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Page 10 of 13parameter values) are widely used in Bioinformatics and
Tree Augmented Naïve bayes [52] (TAN with default
learning parameter values) is a parsimonious version of
Bayesian Networks. To evaluate and compare the quality
of the DM models, the following performance measures
were determined: Precision; Recall; F-measure; ROC; and
Accuracy. To reduce the risk of overfitting, the n-fold
cross validation schema was repeated s times. In brief,
each replicate is associated with a different value of the
seed responsible for the random partitioning of the
Selected Features Learning Data Set. The mean values,
across ten replicates (s = 10), of the performance mea-
sures estimated through the 10-fold cross validation (n =
10), are summarized in the Learning Performance Report.
The minimum (min), mean (mid)a n dm a x i m u m( max)
values of the considered performance measures are
computed.
Validation
DM models were validated, through the Validation task,
by exploiting the Selected Features Validation Data Set.
This data set was obtained by applying the same filters
as applied to the Learning Data Set to the Validation
Data Set, and by using only those features which were
selected through the Feature Selection task applied to
the Pre-processed Learning Data Set.
Functional Gene Selection
Functional Gene Selection (network analysis) determines
the biological significance of the selected gene expression
signature. This task was performed using the Ingenuity
Pathway Analysis (IPA) software package Ver. 8.0 and
content Ver. 2802 which returns graphical representa-
tions of the molecular relationships between input mole-
cules. The IPA GUI is exploited to perform the following
actions; i) to search the corresponding object in the
manually curated Ingenuity’sK n o w l e d g eB a s e( I K B )i n
which the gene symbol is associated with probe set iden-
tifiers (Table 2), ii) to use the selected genes as input into
the IPA Core Analysis; iii) to find direct and indirect
relationships between the genes (network parameters: a)
number of molecules per net equal to 35; b) 25 nets per
analysis) through the analysis algorithm; iv) to edit the
retrieved network (e.g. to delete peripheral nodes) and, to
provide a statistical report concerning relevant pathway
nets together with their functional analysis.
The significance of the association between the list of
genes and the canonical pathway retrieved by IPA was
assessed in two ways: i) the ratio between the number of
molecules from the list that map to the pathway and the
total number of molecules that map to the canonical
pathway. ii) Fisher’s statistic was used to compute the
probability value of the null hypothesis, i.e. the probabil-
ity that the association between the genes included in the
list and the canonical pathway is explained by chance
alone. The goal of this task is twofold: first to find an
explanation for the genes which were selected by the Fea-
ture Selection task and which are included in the IPA
output, and second to understand the reason why some
genes, which were selected by the Feature Selection task,
are not included in the IPA output. Then, the Reduced
set of Features, consisting of the genes included in the
IPA output and/or which are believed to be wrongly not
included in the list of the selected genes is formed. The
Reduced set of Features is then used to perform a new
validation of DM models.
Microarray accession numbers
All microarray data are available from the ArrayExpress
database http://www.ebi.ac.uk/arrayexpress/ under the
following accession codes. Microarrays data accession
number on MGU74Av2 arrays is E-MEXP-2715. Micro-
array on MOE430A and MOE430A 2.0 have the follow-
ing accession numbers for reviewer:
Bordetella pertussis (ID: Reviewer_E-MEXP-3160 PW:
fsEa22df), Bordetella parapertussis (ID: ID:Reviewer_E-
MEXP-3156 PW: o5TTIG2b), Listeria monocytogenes
(ID: Reviewer_E-MEXP-3159 PW: habdgpze), Listeria
innocua (ID: Reviewer_E-MEXP-3158 PW: ojiep0qb),
Lactobacillus paracasei (ID: Reviewer_E-MEXP-3157
PW: mmcbtpma), Lactococcus lactis (ID:Reviewer_E-
MEXP-3162 PW: 3vvnihhg)
Additional material
Additional file 1: Detailed list of the experiments and array types.
Acknowledgements
This work was supported by the grants from European Commission 6th
Framework Program (AIDS-CoVAC), European Commission 7
th Framework
Programs: FIGH-MG 242210 and TOLERAGE 202156, the Italian Ministry of
Education and Research PRIN-COFIN20077NFBH8_003. The authors wish to
thank Donatella Biancolini, and Angela Papagna from the Genopolis
consortium for microarray data generation. We wish to thank Prof. Raffaele
Calogero for critical reading of the manuscript and for helpful discussions.
The authors would like to thank L.Tailleux, and O. Neyrolles who developed
the M.tuberculosis infection model and F. Granucci and I. Zanoni who
generated the BMDC dataset.
Author details
1Genopolis Consortium, University of Milano-Bicocca, Milan, 20126, Italy.
2Department of Informatics, Systems and Communication, University of
Milano-Bicocca, Viale Sarca 336, 20126 Milano, Italy.
3Singapore Immunology
Network, Singapore, 138648, Singapore.
4Department of Biotechnology and
Bioscience, University of Milano-Bicocca, Milan, 20126, Italy.
Authors’ contributions
GTF participated in data collection, pre-processing and participated in
writing the manuscript. VV analyzed the data. PRC participated in generating
the microarray data. FZ participated in the design of the study, data pre-
processing and writing the manuscript. FS designed the KEP protocol, and
participated in writing the manuscript. MF participated in designing the
study, coordinating the study, generating microarray data and writing of the
Tuana et al. BMC Immunology 2011, 12:50
http://www.biomedcentral.com/1471-2172/12/50
Page 11 of 13manuscript. All authors have read and approved the final version of the
manuscript.
Received: 13 April 2011 Accepted: 29 August 2011
Published: 29 August 2011
References
1. Arora A, Simpson DA: Individual mRNA expression profiles reveal the
effects of specific microRNAs. Genome Biol 2008, 9(5):R82.
2. Hobert O: Gene regulation by transcription factors and microRNAs.
Science 2008, 319(5871):1785-1786.
3. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the
genome integrates intrinsic and environmental signals. Nat Genet 2003,
33(Suppl):245-254.
4. Foti M, Ricciardi-Castagnoli P, Granucci F: Gene expression profiling of
dendritic cells by microarray. Methods Mol Biol 2007, 380:215-224.
5. Torri A, Beretta O, Ranghetti A, Granucci F, Ricciardi-Castagnoli P, Foti M:
Gene expression profiles identify inflammatory signatures in dendritic
cells. PLoS One 5(2):e9404.
6. Mortellaro A, Urbano M, Citterio S, Foti M, Granucci F, Ricciardi-Castagnoli P:
Generation of murine growth factor-dependent long-term dendritic cell
lines to investigate host-parasite interactions. Methods Mol Biol 2009,
531:17-27.
7. Foti M, Granucci F, Pelizzola M, Beretta O, Ricciardi-Castagnoli P: Dendritic
cells in pathogen recognition and induction of immune responses: a
functional genomics approach. J Leukoc Biol 2006, 79(5):913-916.
8. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC,
Sabet H, Tran T, Yu X, et al: Distinct types of diffuse large B-cell
lymphoma identified by gene expression profiling. Nature 2000,
403(6769):503-511.
9. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, Levine AJ: Broad
patterns of gene expression revealed by clustering analysis of tumor
and normal colon tissues probed by oligonucleotide arrays. Proc Natl
Acad Sci USA 1999, 96(12):6745-6750.
10. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display
of genome-wide expression patterns. Proc Natl Acad Sci USA 1998,
95(25):14863-14868.
11. Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, Ares M Jr,
Haussler D: Knowledge-based analysis of microarray gene expression
data by using support vector machines. Proc Natl Acad Sci USA 2000,
97(1):262-267.
12. Zhang H, Yu CY, Singer B, Xiong M: Recursive partitioning for tumor
classification with gene expression microarray data. Proc Natl Acad Sci
USA 2001, 98(12):6730-6735.
13. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F,
Schwab M, Antonescu CR, Peterson C, et al: Classification and diagnostic
prediction of cancers using gene expression profiling and artificial
neural networks. Nat Med 2001, 7(6):673-679.
14. Jelinek DF, Tschumper RC, Stolovitzky GA, Iturria SJ, Tu Y, Lepre J, Shah N,
Kay NE: Identification of a global gene expression signature of B-chronic
lymphocytic leukemia. Mol Cancer Res 2003, 1(5):346-361.
15. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P,
Dal Cin P, Ladd C, Feuerhake F, et al: The molecular signature of
mediastinal large B-cell lymphoma differs from that of other diffuse
large B-cell lymphomas and shares features with classical Hodgkin
lymphoma. Blood 2003, 102(12):3871-3879.
16. De Vos J, Thykjaer T, Tarte K, Ensslen M, Raynaud P, Requirand G, Pellet F,
Pantesco V, Reme T, Jourdan M, et al: Comparison of gene expression
profiling between malignant and normal plasma cells with
oligonucleotide arrays. Oncogene 2002, 21(44):6848-6857.
17. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S,
Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for
high-throughput molecular profiling of tumor specimens. Nat Med 1998,
4(7):844-847.
18. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW:
Incipient Alzheimer’s disease: microarray correlation analyses reveal
major transcriptional and tumor suppressor responses. Proc Natl Acad Sci
USA 2004, 101(7):2173-2178.
19. Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C,
Becanovic K, Pouladi MA, Sathasivam K, Cha JH, et al: Mutant huntingtin’s
effects on striatal gene expression in mice recapitulate changes
observed in human Huntington’s disease brain and do not differ with
mutant huntingtin length or wild-type huntingtin dosage. Hum Mol
Genet 2007, 16(15):1845-1861.
20. Huang X, Pan W, Grindle S, Han X, Chen Y, Park SJ, Miller LW, Hall J: A
comparative study of discriminating human heart failure etiology using
gene expression profiles. BMC Bioinformatics 2005, 6:205.
21. Deb K, Raji Reddy A: Reliable classification of two-class cancer data using
evolutionary algorithms. Biosystems 2003, 72(1-2):111-129.
22. Jirapech-Umpai T, Aitken S: Feature selection and classification for
microarray data analysis: evolutionary methods for identifying predictive
genes. BMC Bioinformatics 2005, 6:148.
23. Sun Y, Goodison S, Li J, Liu L, Farmerie W: Improved breast cancer
prognosis through the combination of clinical and genetic markers.
Bioinformatics 2007, 23(1):30-37.
24. Dalton WS, Friend SH: Cancer biomarkers–an invitation to the table.
Science 2006, 312(5777):1165-1168.
25. Niijima S, Kuhara S: Recursive gene selection based on maximum margin
criterion: a comparison with SVM-RFE. BMC Bioinformatics 2006, 7:543.
26. Inza I, Larranaga P, Blanco R, Cerrolaza AJ: Filter versus wrapper gene
selection approaches in DNA microarray domains. Artif Intell Med 2004,
31(2):91-103.
27. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L,
Zimmermann VS, Davoust J, Ricciardi-Castagnoli P: Maturation stages of
mouse dendritic cells in growth factor-dependent long-term cultures. J
Exp Med 1997, 185(2):317-328.
28. Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE, Rocchetti M,
Mingozzi F, Foti M, Chirico G, et al: CD14 regulates the dendritic cell life
cycle after LPS exposure through NFAT activation. Nature 2009,
460(7252):264-268.
29. Witten IH, Frank E: Practical machine learning tools and techniques.
Elsevier; 2005.
30. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, Tanne A,
Castagnoli PR, Gicquel B, Stoker NG, Butcher PD, et al: Probing host
pathogen cross-talk by transcriptional profiling of both Mycobacterium
tuberculosis and infected human dendritic cells and macrophages. PLoS
One 2008, 3(1):e1403.
31. Banchereau J, Palucka AK: Dendritic cells as therapeutic vaccines against
cancer. Nat Rev Immunol 2005, 5(4):296-306.
32. Dhodapkar MV, Steinman RM: Antigen-bearing immature dendritic cells
induce peptide-specific CD8(+) regulatory T cells in vivo in humans.
Blood 2002, 100(1):174-177.
33. Fairchild PJ, Brook FA, Gardner RL, Graca L, Strong V, Tone Y, Tone M,
Nolan KF, Waldmann H: Directed differentiation of dendritic cells from
mouse embryonic stem cells. Curr Biol 2000, 10(23):1515-1518.
34. Senju S, Haruta M, Matsumura K, Matsunaga Y, Fukushima S, Ikeda T,
Takamatsu K, Irie A, Nishimura Y: Generation of dendritic cells and
macrophages from human induced pluripotent stem cells aiming at cell
therapy. Gene Ther .
35. Salguero G, Sundarasetty BS, Borchers S, Wedekind D, Eiz-Vesper B,
Velaga S, Jirmo A, Behrens G, Warnecke G, Knofel AK, et al: Pre-
conditioning therapy with lentivirally reprogrammed dendritic cells
accelerates the homeostatic expansion of antigen-reactive human T
cells in NOD.Rag1 horizontal line/horizontal line. IL-2rgammac horizontal
line/horizontal line mice. Hum Gene Ther .
36. Stroncek DF, Jin P, Ren J, Feng J, Castiello L, Civini S, Wang E, Marincola FM,
Sabatino M: Quality assessment of cellular therapies: the emerging role
of molecular assays. Korean J Hematol 45(1):14-22.
37. Jin P, Han TH, Ren J, Saunders S, Wang E, Marincola FM, Stroncek DF:
Molecular signatures of maturing dendritic cells: implications for testing
the quality of dendritic cell therapies. J Transl Med 8:4.
38. Liu WM, Dennis JL, Fowler DW, Dalgleish AG: The gene expression profile
of unstimulated dendritic cells can be used as a predictor of function.
Int J Cancer .
39. Ma DY, Clark EA: The role of CD40 and CD154/CD40L in dendritic cells.
Semin Immunol 2009, 21(5):265-272.
40. O’Sullivan B, Thomas R: Recent advances on the role of CD40 and
dendritic cells in immunity and tolerance. Curr Opin Hematol 2003,
10(4):272-278.
41. Bastos KR, Marinho CR, Barboza R, Russo M, Alvarez JM, D’Imperio Lima MR:
What kind of message does IL-12/IL-23 bring to macrophages and
dendritic cells? Microbes Infect 2004, 6(6):630-636.
Tuana et al. BMC Immunology 2011, 12:50
http://www.biomedcentral.com/1471-2172/12/50
Page 12 of 1342. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R:
Putting out the fire: coordinated suppression of the innate and adaptive
immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008,
224:265-283.
43. Hand D, Mannila H, Smyth P: Principles of Data Mining. Massachusets
Institute of Technology; 2001.
44. Han J, Kamber M, Pei J: Data Mining: Concepts and Techniques. Morgan
Kaufmann; 2006.
45. Freund Y, Mason L: The alternating decision tree learning algorithm.
Proceeding of the Sixteenth International Conference on Machine Learning:
1999; 1999, 124-133.
46. Cover TM, Hart PE: Nearest neighbor pattern classification. IEEE
Transactions on Information Theory 1967, 13(1):21-27.
47. Quinlan JR: C4.5: Programs for Machine Learning. Morgan Kaufmann;
1993.
48. Agresti A: Categorical Data Analysis. Wiley-Interscience;, Second 2002.
49. Duda RO, Hart PE, Stork DG: Pattern Classification. John Wiley & Sons;,
Second 2001.
50. Breiman L: Random Forests. Machine Learning 2001, 45(1):5-32.
51. Vapnik VN: The Nature of Statistical Learning Theory. Springer-Verlag;
1995.
52. Friedman N, Geiger D, Goldszmidt M: Bayesian Network Classifiers.
Machine Learning 1997, 29(2):131-163.
doi:10.1186/1471-2172-12-50
Cite this article as: Tuana et al.: Classification of dendritic cell
phenotypes from gene expression data. BMC Immunology 2011 12:50.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tuana et al. BMC Immunology 2011, 12:50
http://www.biomedcentral.com/1471-2172/12/50
Page 13 of 13